BioCryst Pharmaceuticals Inc (BCRX)
4.59
-0.02
(-0.43%)
USD |
NASDAQ |
Apr 17, 16:00
4.59
0.00 (0.00%)
After-Hours: 20:00
BioCryst Pharmaceuticals Price: 4.59 for April 17, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 16, 2024 | 4.61 | 4.72 | 4.54 | 4.61 | 1.645M |
Apr 15, 2024 | 4.78 | 4.785 | 4.59 | 4.67 | 2.497M |
Apr 12, 2024 | 5.10 | 5.16 | 4.70 | 4.77 | 4.526M |
Apr 11, 2024 | 4.93 | 5.115 | 4.82 | 5.10 | 3.304M |
Apr 10, 2024 | 4.64 | 4.905 | 4.56 | 4.87 | 2.915M |
Apr 09, 2024 | 4.61 | 4.88 | 4.61 | 4.80 | 1.974M |
Apr 08, 2024 | 4.62 | 4.67 | 4.54 | 4.61 | 1.605M |
Apr 05, 2024 | 4.56 | 4.66 | 4.45 | 4.60 | 1.785M |
Apr 04, 2024 | 4.76 | 4.84 | 4.58 | 4.60 | 2.737M |
Apr 03, 2024 | 4.71 | 4.769 | 4.595 | 4.73 | 3.059M |
Apr 02, 2024 | 4.95 | 5.01 | 4.68 | 4.69 | 4.211M |
Apr 01, 2024 | 5.04 | 5.09 | 4.905 | 5.05 | 4.875M |
Mar 28, 2024 | 5.20 | 5.34 | 5.06 | 5.08 | 3.491M |
Mar 27, 2024 | 5.04 | 5.208 | 4.97 | 5.15 | 2.990M |
Mar 26, 2024 | 5.01 | 5.15 | 4.99 | 5.01 | 3.160M |
Mar 25, 2024 | 5.00 | 5.08 | 4.84 | 4.91 | 2.828M |
Mar 22, 2024 | 5.51 | 5.51 | 5.01 | 5.01 | 3.296M |
Mar 21, 2024 | 5.50 | 5.865 | 5.45 | 5.49 | 2.726M |
Mar 20, 2024 | 5.31 | 5.49 | 5.17 | 5.47 | 3.181M |
Mar 19, 2024 | 5.06 | 5.425 | 5.04 | 5.36 | 3.119M |
Mar 18, 2024 | 5.00 | 5.175 | 4.89 | 5.07 | 4.351M |
Mar 15, 2024 | 4.87 | 5.115 | 4.85 | 5.00 | 10.25M |
Mar 14, 2024 | 5.10 | 5.10 | 4.815 | 4.89 | 4.062M |
Mar 13, 2024 | 5.14 | 5.26 | 5.07 | 5.14 | 2.635M |
Mar 12, 2024 | 5.31 | 5.31 | 5.04 | 5.14 | 3.063M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.585
Minimum
Nov 14 2019
19.76
Maximum
Feb 16 2022
8.391
Average
7.65
Median
Dec 10 2020
Price Benchmarks
AIM ImmunoTech Inc | 0.4909 |
Perspective Therapeutics Inc | 1.425 |
Protalix BioTherapeutics Inc | 1.14 |
Electromed Inc | 14.21 |
Armata Pharmaceuticals Inc | 2.50 |
Price Related Metrics
PS Ratio | 2.662 |
Earnings Yield | -25.71% |
Market Cap | 946.23M |